B. breve MCC1274 administration might exert an ameliorative effect on AD in 17-month-old AppNL-G-F mice partly by reducing chronic stress via inhibiting tau hyperphosphorylation at Thr231 and improving synaptic density and neuronal activation, finally improving cognitive deficits. This evidence concerns the gene MAPT and Alzheimer disease.